Read UMR's July 13 Statement on NIH Funding in House Labor-HHS Appropriations Bill
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
NIH's Role In Sustaining the U.S. Economy | 2023 Update Now Available
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Stanford Medicine joins COVID-19 vaccine trials for children under 12

Stanford Medicine researchers have started enrolling children younger than 12 in clinical trials to evaluate their response to the Pfizer-BioNTech COVID-19 vaccine. Stanford is serving as a site of the Phase 2-3 trial to determine whether the vaccine produces an immune response and prevents COVID-19 in children 5 through 11 years old. It is also a site of the Phase 1 trial to determine the appropriate dose of the vaccine for children 6 months to 5 years old.